Herpes virus-mediated preproenkephalin gene transfer to the amygdala is antinociceptive.
To evaluate the role of the amygdala in pain modulation and opioid-mediated antinociception, a recombinant, replication-defective herpes virus carrying the human preproenkephalin cDNA was injected bilaterally into the rat amygdala. Four days after gene delivery nociceptive behavior was assessed by the formalin test. Rats infected with the virus expressing preproenkephalin showed a selective, naloxone-reversible abolition of phase 2 flinching behavior compared to rats infected with a control virus. The results implicate the amygdala in the control of pain and in opioid analgesia and demonstrate the use of recombinant herpes viruses as tools for studying gene function in specific neural pathways of the central nervous system.
Kang
W
W
Department of Pharmacology, University of South Carolina School of Medicine, Columbia, SC 29208, USA.
Wilson
M A
MA
Bender
M A
MA
Glorioso
J C
JC
Wilson
S P
SP
D000679:Amygdala / Q000201:enzymology / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D004745:Enkephalins / Q000235:genetics*; D018014:Gene Transfer Techniques; D006564:Herpesviridae / Q000235:genetics*; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010146:Pain / Q000235:genetics* / Q000523:psychology*; D010147:Pain Measurement; D011498:Protein Precursors / Q000235:genetics*; D051381:Rats; D001616:beta-Galactosidase / Q000378:metabolism
D004745:Enkephalins; D009292:Narcotic Antagonists; D011498:Protein Precursors; D009270:Naloxone; C033660:preproenkephalin; D001616:beta-Galactosidase